These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19151459)

  • 1. Percutaneous closure of patent foramen ovale without echocardiographic guidance.
    Jamshidi P; Wahl A; Windecker S; Schwerzmann M; Seiler C; Meier B
    Indian Heart J; 2007; 59(6):459-62. PubMed ID: 19151459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients.
    Wahl A; Praz F; Stinimann J; Windecker S; Seiler C; Nedeltchev K; Mattle HP; Meier B
    Swiss Med Wkly; 2008 Oct; 138(39-40):567-72. PubMed ID: 18853285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
    Siddiqui IF; Michaels AD
    J Interv Cardiol; 2011 Jun; 24(3):271-7. PubMed ID: 21114532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
    Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
    JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent foramen ovale closure without echocardiographic control: use of "standby" intracardiac ultrasound.
    Hildick-Smith D; Behan M; Haworth P; Rana B; Thomas M
    JACC Cardiovasc Interv; 2008 Aug; 1(4):387-91. PubMed ID: 19463334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience.
    Mangieri A; Godino C; Montorfano M; Arioli F; Rosa I; Ajello S; Piraino D; Monello A; Pavon AG; Viani G; Magni V; Cappelletti A; Margonato A; Colombo A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):105-12. PubMed ID: 25382155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
    Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell AR; Wilson N; Ormerod OJ
    Int J Cardiol; 2009 Jan; 131(3):438-40. PubMed ID: 18037512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
    Fateh-Moghadam S; Steeg M; Dietz R; Bocksch W
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):361-6. PubMed ID: 19133676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale.
    Oto A; Aytemir K; Ozkutlu S; Kaya EB; Yorgun H; Canpolat U; Ateş AH; Ozkutlu H
    Echocardiography; 2011 Nov; 28(10):1074-80. PubMed ID: 21967656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
    Manolis AS; Koulouris S; Rouska E; Pyrros J
    Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
    Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
    Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow-up.
    Greutmann M; Greutmann-Yantiri M; Kretschmar O; Senn O; Roffi M; Jenni R; Luescher TF; Eberli FR
    Congenit Heart Dis; 2009; 4(4):252-7. PubMed ID: 19664027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiography vs transesophageal echocardiography-guided patent foramen ovale closure: A propensity score matched analysis of a two-center registry.
    Scacciatella P; Meynet I; Giorgi M; Biava LM; Matranga I; Biasco L; Omedè P; Orzan F; Gaita F
    Echocardiography; 2018 Jun; 35(6):834-840. PubMed ID: 29457261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
    Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of patent foramen ovale.
    Bijl JM; Ruygrok PN; Hornung TS; Wilson NJ; West T
    Intern Med J; 2005 Dec; 35(12):706-10. PubMed ID: 16313545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.